Navigation Links
Synthetic Biology: Coming Up Fast!

WASHINGTON Synthetic biology is being touted by scientists and venture capitalists as "the next big thing." Researchers claim to be on the brink of creating artificial life in a laboratory and making the world's first synthetic microbes. The first blockbuster synbio drugan affordable cure for malariais expected on the market by 2010. And a whole new biofuels industry spawned by synthetic biologists that promises to conquer the globe's energy problems seems just around the corner.

But will the promises and pitfalls of synthetic biology catch governments, ethicists, biosafety and biosecurity experts, and the public by surprise? Denise Caruso, former New York Times columnist and longtime analyst of technology-based issues and industries, will explore this question with the Center for American Progress's Rick Weiss. Caruso is the author of Intervention: Confronting the Real Risks of Genetic Engineering and Life on a Biotech Planet (2006). Weiss recently left The Washington Post after a distinguished career as one of the country's foremost science journalists.

Synthetic biology is an emerging area of research that uses advanced science and engineering to make or redesign living organisms, such as bacteria, so that they can carry out specific functions. The Rathenau Instituut describes the field as the convergence of molecular biology, information technology and nanotechnology, leading to the systematic design of biological systems.

This program is being jointly sponsored by the Project on Emerging Nanotechnologies and the Center for American Progress.

To attend the event, RSVP to No RSVP is required to view the Web cast.

*** Webcast LIVE at ***

What: Synthetic Biology: Coming Up Fast!

When: Friday, November 14, 2008, 12:30 1:30 PM (Light lunch available in 6th Floor Board Room prior to the event at 11:45 a.m.)

Who: Denise Caruso, Executive Director & Chair, Hybrid Vigor Institute
Rick Weiss, Senior Fellow, Center for American Progress, Moderator
David Rejeski, Director, Project on Emerging Nanotechnologies, Introduction

Where: Woodrow Wilson International Center for Scholars, 6th Floor Auditorium, in the Ronald Reagan Building at 1300 Pennsylvania Avenue, NW, Washington, DC. For directions see:


Contact: Colin Finan
Project on Emerging Nanotechnologies

Related biology news :

1. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
2. New synthetic form of protein holds promise to stop cancer spread
3. Synthetic moleculues could add spice to fight against cancer
4. Synthetic molecules emulate enzyme behavior for the first time
5. Synthetic cocoa chemical slows growth of tumors in human cell lines
6. Synthetic Biology: funders move to address social and ethical challenges
7. New projects to raise UK profile in synthetic biology
8. Oregano oil works as well as synthetic insecticides to tackle common beetle pest
9. Berkeley researchers identify photosynthetic dimmer switch
10. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
11. Researchers decode genetics of rare photosynthetic bacterium
Post Your Comments:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology: